Abstract:The COVID-19 pandemic presents a major threat to global public health. Several lines of evidence have shown that the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), along with two other highly pathogenic coronaviruses, SARS-CoV and Middle East Respiratory Syndrome (MERS-CoV) originated from bats. To prevent and control future coronavirus outbreaks, it is necessary to investigate the interspecies infection and pathogenicity risks of animal-related coronaviruses. Currently used infection models, including in vitro cell lines and in vivo animal models, fail to fully mimic the primary infection in human tissues. Here, we employed organoid technology as a promising new model for studying emerging pathogens and their pathogenic mechanisms. We investigated the key host-virus interaction patterns of five human coronaviruses (SARS-CoV-2 original strain, Omicron BA.1, MERS-CoV, HCoV-229E, and HCoV-OC43) in different human respiratory organoids. Five indicators, including cell tropism, invasion preference, replication activity, host response and virus-induced cell death, were developed to establish a comprehensive evaluation system to predict coronavirus interspecies infection and pathogenicity risks. Using this system, we further examined the pathogenicity and interspecies infection risks of three SARS-related coronaviruses (SARSr-CoV), including WIV1 and rRsSHC014S from bats, and MpCoV-GX from pangolins. Moreover, we found that cannabidiol, a non-psychoactive plant extract, exhibits significant inhibitory effects on various coronaviruses in human lung organoid. Cannabidiol significantly enhanced interferon-stimulated gene expression but reduced levels of inflammatory cytokines. In summary, our study established a reliable comprehensive evaluation system to analyse infection and pathogenicity patterns of zoonotic coronaviruses, which could aid in prevention and control of potentially emerging coronavirus diseases.

New technique: Development of a large-scale isolation chamber system for the safe and humane care of medium-sized laboratory animals harboring infectious diseases

Facility design and management. Strategies for high level biocontainment

Creation of an experimental rearing environment for microbiome animal research using an individually ventilated cage system and bioBUBBLE enclosure

Creating effective biocontainment facilities and maintenance protocols for raising specific pathogen-free, severe combined immunodeficient (SCID) pigs

Methods for Establishment and Maintenance of Germ-Free Rat Models

Biosafety and data quality considerations for animal experiments with highly infectious agents at ABSL-3 facilities

Development and Application of the Special Sterilizer for P4 Biosafe Laboratory

Establishment of a human organoid-based evaluation system for assessing interspecies infection risk of animal-borne coronaviruses

Accepting Higher Morbidity in Exchange for Sacrificing Fewer Animals in Studies Developing Novel Infection-Control Strategies

Evaluation of an innovative pediatric isolation (PI) bed using fluid dynamics simulation and aerosol isolation efficacy

Design and Husbandry Considerations for a Containment Level 2 Aquatic Facility

An Improved Cdc Isolation Room Ventilation Method for Infection Control

Exploration on Scientific Management of the Laboratory Animals Barrier Housing System in Bengbu Medical College

Design and Application of Biosafe Coronavirus Engineering Systems without Virulence

Minibox: Custom solo or semi-group housing chambers for long term housing of rats with miniscopes

Features of Keeping Laboratory Animals Infected with Pathogenic Biological Agents, Pathogenicity Group I–II, under Experiment

A Practical Assessment of the Disinfectant Efficacy of UV Light with and Without Ozone Using a Novel Transfer Hatch in a Research Animal Facility.

Design and Construction of Specific Pathogen Free(SPF) Laboratory Animal Facility

Laboratory Animals and Zoonotic Infectious Disease

Developing transmissible vaccines for animal infections

Experimental Animals and Quality Control and Development of Veterinary Biologicals